AbCellera Biologics Inc (ABCL) is up Monday morning, with the stock increasing 1.65% in pre-market trading to 21.5. ABCL's short-term technical score of 2 indicates that the stock has traded less bullishly over the last month than 98% of stocks on the market. In the Biotechnology industry, which ranks 137 out of 146 industries, AbCellera Biologics Inc ranks higher than 3% of stocks. AbCellera Biologics Inc has risen 20.31% over the past month, closing at $17.35 on August 30. During this period of time, the stock fell as low as $16.78 and as high as $22.63. ABCL has an average analyst recommendation of Strong Buy. The company has an average price target of $45.25.
ABCL has an Overall Score of 28. Find out what this means to you and get the rest of the rankings on ABCL!